Wound Care Biologics Market, By Product Type (Biologic Skin Substitutes, Enzyme Based Formulations, and Growth factors), By Application (Chronic Wounds (Diabetic Foot Ulcers, Venous Leg Ulcers, and Pressure Ulcers) and Acute Wounds ( Surgical Wounds and Burns)), By End User (Hospital, Clinics, Ambulatory Surgical Centers, and Home Care Settings), and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Trends, Analysis and Forecast till 2030

Report Code: PMI28419 | Publish Date: April 2024 | No. of Pages: 180

Global Wound Care Biologics Market Overview

Wound care biologics are bioengineered products used for non-healing wounds of lower extremity. Wound care biologics involves use of active biological agents such as plant and animal-derived biomolecules which exhibits antioxidant and antimicrobial properties. They used in the post surgeries and trauma cases as they provide moist healing environment aiding heat loss, protein, and prevent bacterial contamination. Biologics used for treatment of wound has grown exponentially in the recent years. Wound care biologics are bioengineered products used for non-healing wounds of the lower extremity. Many different products are also been manufactured to replace or augment various substrates in the wound healing cascade. Wound care biologic dressings are increasingly being used in post surgeries and severe trauma cases as they provide moist healing environment aiding heat loss, protein and electrolyte loss for faster healing, and prevent bacterial contamination. Wound care biologics market accounted for US$ 1.66 billion in 2020 and is estimated to be US$ 3.88 billion by 2030 and is anticipated to register a CAGR of 9.8%.

Regional Insights - Wound Care Biologics Market

Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.

Global Wound Care Biologics Market Dynamics

Increasing incidence of traumatic and other patients

Increasing incidences of traumatic, surgical, ulcers and burn wounds are the major driver factor of wound care biologics. In 2017, according to global diabetes community it was estimated that 422 million adults are living with diabetes globally, and this is expected to increase to 642 million by 2040.

Further, rising medical tourism in Asia Pacific also drives the wound care biologics market. In 2016, according to the survey by Brink Global Risk Center, 2017, around 4 million medical tourists traveled to India for health care services, 3.5 million foreign patients travelled to Thailand and 900,000 patients to Singapore, with the number expected to grow by 10%–14% by 2020.

Moreover, the higher cost of the biologics and stringent regulatory approvals for launch of innovative tissue engineered products are hindering growth of the wound care biologics market.

Access Crucial Insights at a Fraction of the Cost | Request Your Discount

Global Wound Care Biologics Market Segmentation

Wound care biologics market is segmented on the basis of product type, application, end-user, and region.

On the basis of product type, the wound care biologics market is categorized into biologic skin substitutes, enzyme based formulations, and growth factors. On the basis of applications, the target market is classified into chronic wounds and acute wounds. Further, chronic wounds sub-segment is classified into diabetic foot ulcers, venous leg ulcers, and pressure ulcers. Acute wounds sub-segment is segmented into surgical wounds and burns. On the basis of end-user, the wound care biologics market is bifurcated into hospital, clinics, ambulatory surgical centers, and home care settings.

Regional Insights:

On the basis of region, the wound care biologics market has been segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa.  The market in North America is expected to account for major revenue share as compared to that of other regions. This can be attributed to high prevalence of diabetic foot ulcers, high presence of key players, and availability of a variety of wound biologics products in the countries of the region. Also, the market in Europe is expected to account for second-highest revenue share in the global market, followed by the market in Asia Pacific.

Reduce costs by up to 30% with a custom report tailored to your specific needs | Request Customized Report

Attribute

Details

Base year for estimation

2020

Forecast period

2020 – 2030

Market representation

Revenue in USD Million & CAGR from 2020 – 2030

Market Segmentation

By Product Type- Biologic Skin Substitutes, Enzyme Based Formulations, And Growth Factors

By Application- Chronic Wounds And Acute Wounds

By End-User- Hospital, Clinics, Ambulatory Surgical Centers, And Home Care Settings

Regional scope

North America - U.S., Canada

Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe

Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific

Latin America - Brazil, Mexico, Argentina, Rest of Latin America

Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered in Report:

Wound Care Biologics Market, By Product Type:

  • Biologic Skin Substitutes
  • Enzyme Based Formulations
  • Growth factors

Wound Care Biologics Market, By Application:

  • Chronic Wounds
  • Diabetic Foot Ulcers
  • Venous Leg Ulcers
  • Pressure Ulcers
  • Acute Wounds
  • Surgical Wounds
  • Burns

Wound Care Biologics Market, By End User:

  • Hospital
  • Clinics
  • Ambulatory Surgical Centers
  • Home Care Settings

Wound Care Biologics Market, By Region:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • Israel
    • South Africa
    • Rest of Middle East & Africa

Global Wound Care Biologics Market Key Players

Key players operating in the wound care biologics market includes Smith & Nephew Plc., Organogenesis, Inc., Integra Lifesciences Holdings Corporation, Skye Biologics, Inc., Alphatec Holdings, Inc., Solsys Medical, LLC, Amino Technology LLC, and Osiris Therapeutics, Inc.

Global Wound Care Biologics Market Company Profile

  • Smith & Nephew Plc.
    •   Osiris Therapeutics, Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance
    •   Amino Technology LLC
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance
    •  Solsys Medical LLC
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance
    • Alphatec Holdings, Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance
    •  Skye Biologics
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance
    •  Integra Lifesciences Holdings Corporation
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance
    •   Organogenesis, Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance

Global Wound Care Biologics Market Table of Contents

  1. Research Objective and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Preview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By Application
      • Market Snippet, By End User
      • Market Snippet, By Region
    • Opportunity Map Analysis
  3. Market Dynamics Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
      • Market Trends
      • Drivers- Restraints Impact Analysis
      • PEST Analysis
      • Porter’s Five Forces Analysis
  4. Market Segmentation, By Product Type, 2018 – 2029, (US$ Mn)
    • Introduction
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2018 — 2029
      • Y-o-Y Growth Analysis (%), 2019 – 2029
      • Segment Trends
    • Biologic Skin Substitutes
      • Introduction
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2029
    • Enzyme Based Formulations
      • Introduction
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2029
    • Growth Factors
      • Introduction
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2029
  5. Market Segmentation, By Application, 2018 – 2029, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2018 and 2029 (%)
      • Y-o-Y Growth Analysis (%), 2019 – 2029
      • Segment Trends
    • Chronic Wounds
      • Introduction
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2029
        • Diabetic Foot Ulcers
        • Introduction
        • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2029

Venous Leg Ulcers

Introduction

Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2029

  1. Pressure Ulcers
  2. Introduction
  3. Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2029

Acute Wounds

  • Introduction
  • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2029
    • Surgical Wounds
    • Introduction
    • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2029

Burns

  • Introduction
  • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2029

Market Segmentation, By End User, 2018 – 2029, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2018 and 2029 (%)
    • Y-o-Y Growth Analysis (%), 2019 – 2029
    • Segment Trends
  • Hospital
    • Introduction
    • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2029
  • Clinics
    • Introduction
    • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2029
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2029
  • Home Care Settings
    • Introduction
    • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2029

Global Market, By Region, 2018 – 2029, (US$ Mn)

  • Introduction
    • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2018 — 2029
    • Y-o-Y Growth Analysis (%), 2019 – 2029
    • Regional Trends
  • North America
    • Market Size and Forecast (US$ Mn), By Product Type, 2018 – 2029
    • Market Size and Forecast (US$ Mn), By Application, 2018 – 2029
    • Market Size and Forecast (US$ Mn), By End User, 2018 – 2029
    • Market Size and Forecast (US$ Mn), By Country, 2018 – 2029
      • U.S.
      • Canada
  • Latin America
    • Market Size and Forecast (US$ Mn), By Product Type, 2018 – 2029
    • Market Size and Forecast (US$ Mn), By Application, 2018 – 2029
    • Market Size and Forecast (US$ Mn), By End User, 2018 – 2029
    • Market Size and Forecast (US$ Mn), By Country, 2018 – 2029
      • Brazil
      • Mexico
      • Argentina and Chile   
      • Rest of Latin America
  • Europe
    • Market Size and Forecast (US$ Mn), By Product Type, 2018 – 2029
    • Market Size and Forecast (US$ Mn), By Application, 2018 – 2029
    • Market Size and Forecast (US$ Mn), By End User, 2018 – 2029
    • Market Size and Forecast (US$ Mn), By Country, 2018 – 2029
      • Germany
      • UK
      • France
      • Russia
      • Italy
      • Switzerland
      • Sweden
      • Rest of Europe           
  • Asia Pacific
    • Market Size and Forecast (US$ Mn), By Product Type, 2018 – 2029
    • Market Size and Forecast (US$ Mn), By Application, 2018 – 2029
    • Market Size and Forecast (US$ Mn), By End User, 2018 – 2029
    • Market Size and Forecast (US$ Mn), By Country, 2018 – 2029
      • China
      • India
      • Australia & New Zealand
      • Japan
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast (US$ Mn), By Product Type, 2018 – 2029
    • Market Size and Forecast (US$ Mn), By Application, 2018 – 2029
    • Market Size and Forecast (US$ Mn), By End User, 2018 – 2029
    • Market Size and Forecast (US$ Mn), By Country, 2018 – 2029
      • GCC
      • Israel
      • Saudi Arabia
      • UAE
      • Rest of Middle East
  • Africa
    • Market Size and Forecast (US$ Mn), By Product Type, 2018 – 2029
    • Market Size and Forecast (US$ Mn), By Application, 2018 – 2029
    • Market Size and Forecast (US$ Mn), By End User, 2018 – 2029
    • Market Size and Forecast (US$ Mn), By Country, 2018 – 2029
      • North Africa
      • Central Africa
      • South Africa
  1. Competitive Landscape
    • Heat Map Analysis
    • Company Profiles
      • Smith & Nephew Plc.*
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Business Strategy Overview
      • Organogenesis, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Business Strategy Overview
      • Integra Lifesciences Holdings Corporation
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Business Strategy Overview

§  Skye Biologics

  1. Company Overview
  2. Product Portfolio
  3. Key Highlights
  4. Financial Overview
  5. Business Strategy Overview
  6. Alphatec Holdings, Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Business Strategy Overview
  7. Solsys Medical LLC
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Business Strategy Overview
  8. Amino Technology LLC
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Business Strategy Overview
  9. Osiris Therapeutics, Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Business Strategy Overview
  10. Analyst Views

Section

  • Research Methodology
  • About Us
  • Contact

FAQs

The global wound care biologics market accounted for US$ 1.66 billion in 2020 and is estimated to be US$ 3.88 billion by 2030 and is anticipated to register a CAGR of 9.8%.

The Global Wound Care Biologics Market is projected to increase at a CAGR of 9.8% during the forecast.

Global wound care biologics market is segmented on the basis of product type, application, end-user, and region.

Increasing incidences of traumatic, surgical, ulcers and burn wounds are the major driver factor of wound care biologics.